Physician

Matthew Shupe, D.O.

According to 2025 Medicare claims, Matthew Shupe, D.O. (NPI: 1629206750) practices medical oncology in the Lincoln, NE market, with the plurality of this provider's patient population coming from Lancaster, NE. This provider's primary affiliated billing organization is NEBRASKA HEMATOLOGY-ONCOLOGY, PC (NPI: 1205915071; TIN: 911806105) and primary practice location at 68506-7548. Shupe is affiliated with the NPG Health Collaborative LLC (ACO ID: A3287), Bryan Health Connect ACO, LLC (ACO ID: A4573), Caravan Collaborative Pathways (ACO ID: A4604), and Main Street Rural Health Maple ACO LLC (ACO ID: A5401), participating under the MSSP model.

Shupe's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 684 traditional Medicare patients, billed 148,146 HCPCS/CPT codes, and received $2,523,619 in Medicare payments. The top billing code was 99214 (Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more). Part D data shows 365 prescription claims across 94 beneficiaries totaling $816,542 in drug costs, led by Revlimid (Lenalidomide). Open Payments data shows 12 records totaling $222. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has risen steadily, from $5,581 to $2,523,619. Similarly, Part D prescription costs have risen steadily, from $54,481 to $816,542. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.